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Abstract
Background: Differentiating cerebral malaria (CM) from other causes of serious illness in African children is problematic,
owing to the non-specific nature of the clinical presentation and the high prevalence of incidental parasitaemia. CM is
associated with endothelial activation. In this study we tested the hypothesis that endothelium-derived biomarkers are
associated with the pathophysiology of severe malaria and may help identify children with CM.
Methods and Findings: Plasma samples were tested from children recruited with uncomplicated malaria (UM; n=32),
cerebral malaria with retinopathy (CM-R; n=38), clinically defined CM without retinopathy (CM-N; n=29), or non-malaria
febrile illness with decreased consciousness (CNS; n=24). Admission levels of angiopoietin-2 (Ang-2), Ang-1, soluble Tie-2
(sTie-2), von Willebrand factor (VWF), its propeptide (VWFpp), vascular endothelial growth factor (VEGF), soluble ICAM-1
(sICAM-1) and interferon-inducible protein 10 (IP-10) were measured by ELISA. Children with CM-R had significantly higher
median levels of Ang-2, Ang-2:Ang-1, sTie-2, VWFpp and sICAM-1 compared to children with CM-N. Children with CM-R had
significantly lower median levels of Ang-1 and higher median concentrations of Ang-2:Ang-1, sTie-2, VWF, VWFpp, VEGF and
sICAM-1 compared to UM, and significantly lower median levels of Ang-1 and higher median levels of Ang-2, Ang-2:Ang-1,
VWF and VWFpp compared to children with fever and altered consciousness due to other causes. Ang-1 was the best
discriminator between UM and CM-R and between CNS and CM-R (areas under the ROC curve of 0.96 and 0.93, respectively).
A comparison of biomarker levels in CM-R between admission and recovery showed uniform increases in Ang-1 levels,
suggesting this biomarker may have utility in monitoring clinical response.
Conclusions: These results suggest that endothelial proteins are informative biomarkers of malarial disease severity. These
results require validation in prospective studies to confirm that this group of biomarkers improves the diagnostic accuracy
of CM from similar conditions causing fever and altered consciousness.
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Introduction
Differentiating cerebral malaria (CM) from other conditions
causing fever and altered consciousness is a clinical challenge,owing
to the non-specific clinical presentations of CM (fever, coma,
convulsions) and the high prevalence of incidental parasitaemia in
malaria-endemic areas [1,2,3,4]. In a study of African children
diagnosedwith CM,approximatelyonequarterwere showntohave
alternative causes for their neurological syndrome at post-mortem
examination [1]. These findings indicate that CM is over-
diagnosed, a situation that is likely to have serious consequences
for children in whom other treatable or life-threatening conditions
are not identified [1,5]. There is a clear need for a diagnostic test
that could distinguish CM from other conditions causing enceph-
alopathy in malaria-endemic areas. In comatose African children, a
distinctive retinopathy consisting of haemorrhages, patchy retinal
whitening and vessel changes is strongly associated with malaria
being the only identifiable cause of death [1].
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mature parasitized erythrocytes to the microvasculature of vital
organs and acute endothelial activation (reviewed in [6]; [7]).
Exocytosis of Weibel-Palade bodies (WPBs) occurs in association
with endothelial activation and the products of WPBs have been
identified as biomarkers of malarial disease severity [8,9,10]. WPBs
release bioactive products, including von Willebrand factor (VWF),
its propeptide (VWFpp), and angiopoietin-2 (Ang-2) into the
systemic circulation. Together with vascular endothelial growth
factor (VEGF), the angiogenic factors angiopoietin-1 (Ang-1) and
Ang-2, are major regulators of the vascular inflammatory response,
endothelial activation and endothelial integrity [11,12]. Ang-1 is
constitutively released from perivascular cells including pericytes and
smooth muscle cells and signals through the Tie-2 receptor to
maintainvascularquiescenceandstability. Ang-2antagonizes Ang-1
function resulting in endothelial activation and increased vascular
permeability. Ang-2 sensitizes the endothelium to sub-threshold
levels of tumour necrosis factor, resulting in increased expression of
adhesion molecules such as ICAM-1 to which parasitized erythro-
cytes bind [13]. VEGF induces WPB exocytosis, mediates Tie-2
shedding, and regulates Ang-1 and Ang-2 function [11,14]. Tie-2 is
the cognate receptor for Ang-1 and Ang-2 and the soluble form of
the receptor, sTie-2, can bind the angiopoietins and regulate their
function. WPBs are also an important source of VWF, particularly
ultralarge multimers (ULVWF) that are considered biologically
hyperactive with respect to their enhanced binding avidity for
collagen and platelets [15]. Severe malaria has been associated with
increased levels of VWF and ULVWF multimers and decreased
levels of the regulatory VWF-specific cleaving protease ADAMTS13
(A disintegrin and metalloprotease with thrombospondin type-1
repeats) [9]. ICAM-1 is a receptor for the cytoadherence of mature
parasitized erythrocytes in the cerebral microvasculature and its
soluble form (sICAM-1) has been used as a marker of endothelial
activation and severe malaria [7,16,17]. In addition to the molecular
markers and regulators of endothelial quiescence and activation, IP-
10, an interferon-gamma inducible chemokine involved in recruit-
mentof activated Th1cells,hasbeenreportedasabiomarkeroffatal
CM in studies from India and Ghana [18,19].
Reliable diagnostic and prognostic biomarkers for CM and
other forms of severe malaria may improve clinical management,
resource allocation and outcome of serious childhood illness. The
aim of this study was to evaluate the ability of endothelial
biomarkers to discriminate between different clinical disease states
in malaria and between cerebral malaria and other conditions
associated with fever and altered consciousness in Malawian
children. We show that endothelium-based proteins are informa-
tive biomarkers of disease severity and clinical response and that a
panel of biomarkers can discriminate between retinopathy positive
CM and uncomplicated malaria or other CNS infections with a
high degree of accuracy. Further, we demonstrate that a distinctive
set of endothelium-based proteins is associated with retinopathy in
a group of children with coma and parasitaemia.
Methods
Ethics Statement
Ethical approval for this study was granted from The College of
Medicine Research Committee in Blantyre, Malawi (COMREC)
and all parents or guardians gave written informed consent for
children to enter the study.
Study Population
This study was nested within prospective studies examining the
pathogenesis and management of CM and central nervous system
infections [1,20,21]. Convenience samples were selected for
children between 1 month and 14 years of age presenting with
fever to the Queen Elizabeth Central Hospital (QECH) in
Blantyre, Malawi between 1997 and 2009, who met the eligibility
criteria for the clinical syndromes and had sufficient plasma
samples available. Admission lithium heparin plasma samples were
obtained from children after their parents or guardians had given
their informed consent. Clinical and demographic data were
collected from cases and controls at the time of blood collection,
and all subsequent analyses were carried out blind to these details.
Efforts were made to minimize bias by selecting subjects from a
single population (children presenting to QECH), and by using
two types of controls, uncomplicated malaria illness (outpatient)
and non-malarial febrile illness with decreased consciousness
(inpatient). All participants received standard treatment, including
antimalarial and/or antibacterial therapy as indicated, according
to Malawian National guidelines.
Ophthalmological Examination
After admission of a child with altered consciousness, the
patient’s pupils were dilated by application of drops (tropicamide
and phenylephrine) and the fundi were examined by direct and
indirect ophthalmoscopy. The findings of an ophthalmologist or
experienced clinician were recorded on standardized forms.
Retinopathy was defined by the presence of any one or more of
the following retinal findings: white-centered haemorrhages,
retinal whitening, or vessel changes, with or without papilloedema,
as previously described [20,21]. Papilloedema alone did not
constitute retinopathy.
Definitions of clinical syndromes
Cerebral Malaria (CM). Children meeting the case
definition for CM [1,5] including P. falciparum asexual parasi-
taemia, a Blantyre coma score #2 with no improvement following
correction of hypoglycemia, and no evidence of an alternative
cause for coma including meningitis on examination of
cerebrospinal fluid, were eligible for enrolment. Children’s fundi
were examined and they were classified as retinopathy positive
(CM-R) or retinopathy negative (CM-N). CM-R children were
considered to be confirmed CM and were used for all analyses
comparing clinical groups. Paired admission and 28 day
convalescence plasma samples (representing clinical recovery)
were collected for each surviving child available for follow-up.
Uncomplicated Malaria (UM). Children were included in
the UM group if they presented to the outpatient clinic at Queen
Elizabeth Central Hospital, Blantyre, Malawi with febrile illness
and a blood film positive for asexual P. falciparum without another
explanation for fever, and with no malarial complications.
CNS controls. Children with non-malarial fever and altered
consciousness were included in the study as a further comparator
group. Samples were taken from a study looking at suspected
central nervous system (CNS) infections (unpublished data).
Children with fever or history of fever, a negative malarial
smear and at least one of the following: reduced level of
consciousness, Blantyre coma score (BCS) #4, neck stiffness,
photophobia, Kernig’s sign, tense fontanelle, focal neurological
signs, convulsions, or unexplained irritability in infants, were
eligible for enrolment.
Quantification of Biomarkers
Plasma concentrations of biomarkers Ang-1, Ang-2, sTie-2,
VEGF-A, IP-10 and sICAM-1 (DuoSets, R&D Systems, Minne-
apolis, MN), von Willebrand factor (VWF [capture REF P0226,
detection REF A0082]: DAKO, Denmark A/S) and von Will-
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CLB-Pro 14.3 HRP conjugated]: Sanquin, Netherlands) were
measured by ELISA as follows. According to the manufacturer’s
instructions, capture antibodies were diluted in PBS (Gibco)
overnight at 4uC and were washed with PBS 0.05% Tween 20
(Sigma) five times and blocked for a minimum of 2 hours in PBS
1% BSA (reagent diluent). The samples were then diluted in
reagent diluent and standard curves were generated using
recombinant proteins (R&D Systems). Normal plasma from a
pool of 40 healthy adult Caucasian donors served as a standard for
VWFpp and VWF. The plasma pool contained 5.5 nM of
VWFpp and 49 nM of VWF. Samples were plated in duplicate
and incubated overnight at 4uC, washed five times and detection
antibodies were added according to manufacturer recommended
dilutions for 2 hours at room temperature (RT). For Ang-1 and
Ang-2, the detection antibodies were resuspended one hour prior
to use with 2% heat inactivated goat or mouse serum respectively.
Following wash steps (76), VWF and VWFpp were developed
using TMB (eBioscience) and the reaction was stopped using 2N
H2SO4. The plate was read at 450 nM (Dynex Technologies
Opsys MR plate reader) and concentrations were extrapolated
from the standard curve (4-PL) using revelation Quicklink software
(v4.04). The ELISA assays from R&D systems were washed (76)
and Extravidin-Alkaline phosphatase (AP) (Sigma) was added
1:1000 to each well for 1 hour at RT. The plates were then
washed a final time (76 in PBS 0.05% Tween 20 and 26 in
deionized water) before adding the substrate p-nitrophenyl
phosphate (pNPP) (Sigma). The plates were read at 405 nM and
concentrations were extrapolated as above.
Statistics
Data were analyzed in GraphPad Prism v5.0 and SPSS v16.0.
All analyses were non-parametric with Spearman’s correlation for
two-way correlations between biomarkers, Mann-Whitney U tests
to compare biomarkers between groups with Holms correction for
multiple testing, and receiver operating characteristic (ROC)
curves to assess the diagnostic accuracy of the tests. Optimal test
thresholds were derived mathematically from the ROC curves
using the point on the ROC curve with the lowest value for the
formula: (1- sensitivity)
2 + (1-specificity)
2. Wilcoxon matched pairs
test was used to compare biomarker levels measured at admission
and convalescence.
Results
Patient Characteristics
A total of 123 febrile children with either UM (n=32),
suspected CNS infections (n=24), or CM (n=67) were included
in the study. Of the children that met study criteria for CM, 38
were retinopathy positive and were classified as retinopathy-
validated CM (CM-R); whereas the other 29 had normal ocular
fundi (CM-N) [21]. Children with CM-R were significantly
younger than children with clinically defined CM without
retinopathy. Demographic and clinical data for these children
are shown in Table 1.
Endothelial biomarkers differentiate retinopathy positive
CM cases from those without retinopathy
Since retinopathy has been established as a discriminant tool in
the diagnosis of CM, we examined biomarker levels in children
with CM and malaria retinopathy (CM-R) and compared them to
children with clinical CM without retinopathy (CM-N). Individ-
ually, Ang-2, Ang-2:Ang-1, sTie-2, VWFpp and sICAM-1 were
significantly associated with retinopathy (Figure 1, Table 2). For
each analyte tested, a receiver operating characteristic (ROC)
curve was generated to assess the diagnostic accuracy of the
biomarker to discriminate between CM-N and CM-R. The area
under the ROC (AUROC) curve was computed and the
sensitivity, specificity and positive and negative likelihood ratios
were calculated at the optimal biomarker cut-off. sTie-2 and Ang-
Table 1. Demographic and clinical characteristics of study population.
CM CNS UM
CM-R CM-N
Number 38 29 24 32
Age, Months 33 (13–82) ** 51(14–159) 26 (1–109) , 39 (8–96)
Female, n (%) 17 (44.7) 11 (37.9) 9 (37.5) 17 (53.2)
Presenting BCS 1 (0–2) 1 (0–2) 4 (3–5) + 5
Severe Anaemia, n (%) 28 (73.7%) *** 2 (6.9) 1 (4.5) , 0
Admission Parasitaemia 62,956 (86–1,729,160) 43,631 (36–1,626,240) 0 (0–0) +
#
CSF White Cell Count 0 (0–17) 0 (0–15) 2 (0–6) , {
History of Convulsions, n (%) 30 (78.9) 27 (93.1) 8 (44.4){, , {
White Blood Cell Count 9900 (2,800–25,700) 8,800 (1,400–28,000) {{
Platelet count 45,000 (5,000–262,000) 116,000 (6,000–545,000) {{
Venous Lactate 6.35 (2.4–16.4) 5.0 (1.6–21.4) {{
CM: retinopathy positive (CM-R), retinopathy negative (CM-N). Median (range) unless otherwise indicated;
#Clinical information unavailable as children seen on an outpatient basis;
**p,0.01;
***p,0.001 (CM-R vs. CM-N);
{N=18;
{ Unavailable;
, p,0.01;
+ p,0.0001 (CM vs. CNS);
BCS: Blantyre Coma Score.
doi:10.1371/journal.pone.0015291.t001
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of 0.83 (95% CI: 0.73–0.93) and 0.77 (95% CI: 0.65–0.89)
respectively.
Endothelial biomarkers differ between CM and UM
We compared admission levels of plasma biomarkers in children
with CM-R (n=38) to children with UM (n=32). The median
concentration of Ang-1 was significantly lower, and median levels
of Ang-2:Ang-1, sTie-2, VWFpp, VWF, sICAM, VEGF were
significantly higher in patients with CM-R than in patients with
UM (Figure 2, Table 3).
ROC curves were generated to assess the diagnostic accuracy of
the biomarkers to discriminate between UM and CM-R. The
AUROC curve was computed and the sensitivity, specificity and
positive and negative likelihood ratios were calculated at the
optimal biomarker cut-off (Table 4). Ang-1, sTie-2, VWFpp,
VWF, ICAM, VEGF were each able to differentiate between UM
and CM-R whereas IP-10 was not. Although Ang-2 on its own was
no longer significant after correcting for multiple comparisons, the
Ang-2:Ang-1 ratio had an AUROC as good as Ang-1 and resulted
in an improved positive likelihood ratio (LR(+)) versus Ang-1 alone
[Ang-1 LR(+)=7.1 compared to Ang-2:Ang-1 LR(+)=18].
Distinct biomarker profiles in CM differ between
retinopathy validated CM and other causes of fever and
altered mental status
Distinguishing CM-R from other causes of fever and altered
level of consciousness is clinically challenging yet critical for
instituting timely, specific, and potentially life-saving treatment.
We hypothesized that CM-R is associated with a characteristic
Figure 1. Endothelial biomarkers are associated with retinopathy (CM-R) in children with clinically defined cerebral malaria. Graphs
showing the median and scatter of plasma biomarkers (A) Ang-2 (ng/mL), (B) Ang-1(ng/mL), (C) Ang-2:Ang-1, (D) VWF propeptide (VWFpp, mmol/L),
(E) VWF (mmol/L), (F) sTie-2 (ng/mL), (G) sICAM-1 (ng/mL), (H) VEGF (ng/mL) and (I) IP-10 (ng/mL) levels in retinopathy negative cerebral malaria (CM-
N) or retinopathy positive cerebral malaria (CM-R) as measured by ELISA (Mann-Whitney). ns (not significant, p.0.05), *p,0.05 after Holms correction
for multiple comparisons (9 pair-wise comparisons). The limit of detection is represented by a dotted line (VEGF).
doi:10.1371/journal.pone.0015291.g001
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clinically informative in distinguishing CM-R from other causes of
fever and altered consciousness. Comparing children with CM-R
(n=38) to a control group of children admitted with non-malarial
febrile illness and altered level of consciousness (CNS) (n=24),
median Ang-1 levels were lower, and median Ang-2, Ang-2:Ang-1,
VWFpp and VWF higher in children with CM-R compared to
CNS controls (Figure 2, Table 3).
Using ROC curve analysis, three biomarkers, Ang-1, VWFpp,
and VWF, discriminated children with CM-R from children with
other suspected CNS infections (Table 5). Median Ang-2 was
elevated in CM-R compared to the CNS controls, and the Ang-
2:Ang-1 ratio had an AUROC equal to that of Ang-1 alone but
with a two-fold increase in the positive likelihood ratio (Table 5).
sICAM-1, sTie-2, and VEGF, while useful biomarkers for UM vs.
CM-R, did not discriminate between CM-R vs. CNS (Table 5).
Correlation between endothelial biomarkers
Complex interactions have been reported between molecular
regulators of endothelial function [12]. Therefore we postulated
that significant correlations would exist between endothelial
biomarkers. After applying two-way rank correlations we found
significant correlations between Ang-2 and sTie-2, VWFpp, VWF,
sICAM-1, and IP-10 and inverse correlations between Ang-1,
Ang-2, VWF, VWFpp, sICAM-1 and IP-10 (Table 6). Most of the
endothelial biomarkers were significantly associated with each
other, except for VEGF, which was only associated with IP-10.
Endothelial biomarker levels are associated with clinical
recovery
We hypothesized that sequential measurements of endothelial
biomarker levels could provide objective and quantitative evidence
of clinical recovery and disease resolution. To test this hypothesis,
we obtained paired measurements of endothelial biomarkers at
admission and at day 28, following treatment and recovery, from
38 survivors of CM-R. Levels of Ang-1 displayed a uniform and
consistent increase in all participants, whereas levels of Ang-2, Tie-
2, VWFpp, VWF, sICAM-1, and IP-10 decreased with convales-
cence (Figure 3, Table S1). Overall, VEGF showed a significant
increase in levels at convalescence (Table S1). Notably, the Ang-
2:Ang-1 ratio showed the most dynamic range between levels at
admission and follow-up and there was a universal and consistent
decrease in Ang-2:Ang-1 levels associated with clinical recovery.
Discussion
The diagnosis of cerebral malaria in children is clinically
challenging since the syndrome may be confused with other causes
of fever and altered consciousness. Diagnostic tools that could
accurately identify children with ‘‘true’’ CM would enable
improved triage and management of these life-threatening
infections. Currently retinopathy is the best tool to predict which
febrile, comatose children have true CM [1,20–22], but it has
operational constraints. Alternative methods of discriminating
between these groups have not been described. Identifying
retinopathy in a comatose child greatly increases the confidence
with which the clinical syndrome can be attributed to malaria.
Direct ophthalmoscopy through dilated pupils can be used to
observe retinal changes, but a more accurate picture is provided
by indirect ophthalmoscopy, a procedure that is usually not
available where resources are limited. In this study, we tested the
hypothesis that plasma biomarkers may function as surrogate
markers for malarial retinopathy. We show that several biomark-
ers (Ang-2, sTie-2, VWFpp and sICAM-1) were significantly
associated with retinopathy in children with clinical defined CM
(Fig. 1, Table 2). We report that a panel of endothelial and
angiogenic biomarkers is able to discriminate, with a high degree
of accuracy, children with retinopathy-confirmed CM (CM-R)
from those with uncomplicated infection (UM) or with non-
malarial febrile illness and altered consciousness (CNS controls)
(Fig. 2. Table 3&4). This is the first study to demonstrate the
specificity of Ang-1 for CM in children, and we confirm and
extend previous observations of elevated levels of VWFpp and
VWF in children with severe malaria compared to non-malarial
febrile illness [8]. Further, we show a marked and uniform
decrease in Ang-2:Ang-1 at follow-up (Fig. 3), suggesting that the
ratio between these two proteins may offer an approach to
monitor clinical response. This study represents a significant
extension to previous studies of endothelial biomarkers in malaria
as it includes a retinopathy-confirmed group of children with
cerebral malaria and also includes children with decreased
consciousness due to other febrile illnesses. Finally, we are able
Table 2. Endothelial-biomarkers are associated with retinopathy in a cohort of children with cerebral malaria (CM).
AUROC CM-R
vs CM-N p-value Cutoff
Sensitivity
(95%CI)
Specificity
(95%CI)
Positive
likelihood
ratio (95% CI)
Negative
likelihood
ratio (95% CI)
Ang-1 0.64 (0.51–0.78) 0.046 3.2 68 (53–81) 44 (28–62) 1.2 (0.84–1.8) 0.70 (0.38–1.3)
Ang-2 0.77 (0.65–0.89) ,0.0001* 6.2 71 (55–83) 72 (54–85) 2.6 (1.4–4.8) 0.40(0.23–0.69)
Ang-2:Ang-1 0.74 (0.60–0.87) 0.001* 2.0 74 (58–85) 66 (47–80) 2.1 (1.3–3.7) 0.40 (0.22–0.73)
sTie-2 0.83 (0.73–0.93) ,0.0001* 56 74 (58–85) 72 (54–85) 2.7 (1.4–5.0) 0.36 (0.20–0.65)
VWF propeptide 0.71 (0.58–0.85) 0.005* 51 76 (61–87) 62 (44–77) 2.0 (1.2–3.3) 0.38 (0.20–0.72)
VWF 0.58 (0.42–0.73) 0.305 310 68 (53–81) 58 (41–74) 1.7 (1.0–2.7) 0.54 (0.31–0.94)
sICAM-1 0.73 (0.59–0.86) 0.006* 1000 71 (55–83) 69 (51–83) 2.3 (1.3–4.1) 0.42 (0.24–0.73)
VEGF 0.65 (0.52–0.79) 0.040 0.25 74 (58–85) 58 (39–74) 1.7 (1.1–2.8) 0.46(0.24–0.85)
IP-10 0.58 (0.43–0.73) 0.312 0.71 66 (50–79) 54 (36–70) 1.4 (0.90–2.2) 0.64 (0.37–1.1)
Median (range), Mann-Whitney U test;
*p,0.05 after Holms correction for 9 pair-wise comparisons;
CM-R: Cerebral malaria, retinopathy positive
CM-N: Cerebral malaria, retinopathy negative, AUROC: Area under the receiver operating characteristic curve.
doi:10.1371/journal.pone.0015291.t002
Biomarkers for Cerebral Malaria
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15291to go beyond description to examine different putative causal
biomarkers of endothelial activation and postulate on their role in
disease pathogenesis and clinical recovery.
The endothelium is a dynamic organ system representing the
interface between the vascular space and vital organs. The
regulation of endothelial integrity is of critical importance,
particularly in the face of infection-related injury. Endothelial
adhesion of parasitized red cells and endothelial activation are
prominent features in the pathology of fatal malaria. Parasitized
erythrocytes bind to the endothelium directly through endothelial
receptors and may indirectly bind through VWF and platelet
complexes [23]. There is evidence to suggest that blood-brain-
barrier dysfunction and breakdown occurs in paediatric CM [24–
26]. However, the pathophysiology of CM is poorly understood. A
detailed understanding of endothelial activation and regulation
during infection may provide new insights into the molecular basis
of severe and fatal malaria.
Angiopoietins are critical regulators of endothelial activation
and integrity. Elevated Ang-2 levels have previously been
associated with severe malaria in paediatric and adult populations
and strategies to block Ang-2 have been suggested as novel
interventions for severe malaria [10,27,28]. In this study, Ang-2
was elevated in CM-R compared to UM and CNS controls but
became of borderline significance after correcting for multiple
comparisons. However, inclusion of Ang-2 as a component of the
Ang2:Ang-1 ratio markedly improved the specificity and positive
likelihood ratio compared to Ang-1 or Ang-2 alone. Levels of Ang-
2 observed in this study were lower than those reported in
Figure 2. Endothelial biomarkers differentiate retinopathy validated cerebral malaria (CM-R) from uncomplicated malaria (UM) and
children with fever and decreased consciousness due to other causes (CNS). Graphs showing the median and scatter of plasma biomarkers
(A) Ang-2 (ng/mL), (B) Ang-1(ng/mL), (C) Ang-2:Ang-1, (D) VWF propeptide (VWFpp, mmol/L), (E) VWF (mmol/L), (F) sTie-2 (ng/mL), (G) sICAM-1 (ng/
mL), (H) VEGF (ng/mL) and (I) IP-10 (ng/mL) levels in UM, non-malarial febrile illness with decreased consciousness (CNS) or retinopathy validated
cerebral malaria (CM-R) as measured by ELISA (Mann-Whitney). ns (not significant, p.0.05), *p,0.05 after Holms correction for multiple comparisons
(9 pair-wise comparisons). The limit of detection is represented by a dotted line (VEGF).
doi:10.1371/journal.pone.0015291.g002
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attributable to the present study design that excluded fatal cases,
in which Ang-2 levels are highest. Ang-2 has been associated with
increased disease severity [10,28] and increased risk of death [10]
in Asian adults with severe malaria. Together, these data suggest
that changes in Ang-2 are reflective of disease severity and
mortality and may be a good surrogate endpoint for trials
investigating mortality or evaluating adjunctive therapies. In the
context of endothelial biology, the balance between Ang-1 and
Ang-2 regulates the functional responsiveness of the endothelium.
Ang-1 is synthesized by peri-endothelial cells to promote vascular
quiescence under normal physiologic conditions; however, the
release of Ang-2 from WP bodies can inhibit Ang-1 signalling in a
dose-dependent manner, resulting in local destabilization of the
endothelium [29]. In this study, there were markedly lower Ang-1
levels at presentation in children with CM-R compared to those
with UM or the CNS controls. The observed decreases in Ang-1
levels combined with increases in Ang-2 may contribute to the
endothelial dysfunction observed in CM.
The functions of Ang-1 and Ang-2 are also modulated by
interactions with VEGF. Under normal physiological conditions of
high Ang-1 and low Ang-2, VEGF can stabilize the endothelium
in an anti-apoptotic state and be neuroprotective [30,31].
However, when Ang-1 levels are low, VEGF can act on the
endothelium unopposed, resulting in the upregulation of Ang-2
mRNA, exocytosis of WP bodies, increased permeability of
endothelial cells and upregulation of tissue factor and ICAM-
1[32–36]. This may be particularly important in the context of
paediatric CM, where coagulopathy and increased tissue factor
expression may occur and Ang-1 levels are low [37,38]. In this
study, VEGF was elevated in children with retinopathy confirmed
CM compared to children with uncomplicated malaria. These
findings are in contrast to reports examining VEGF in severe
malaria in adults from Southeast Asia, which have reported a
decrease in VEGF in fatal CM cases [19] and decreased VEGF
associated with increased disease severity [10]. These studies
postulate that VEGF may be neuroprotective and associated with
wound healing [19], or may reflect the accumulation of VEGF
within the parasitophorous vacuole [10,39]. Other reports from
children have shown no difference in CSF levels of VEGF between
deaths due to malaria vs. those attributed to other causes [18].
However, a study of Kenyan children with CM showed plasma
VEGF levels were positively correlated with TNF and inversely
correlated with a neuroprotective agent, erythropoietin, and high
levels of plasma VEGF were associated with an increased risk of
seizures, raised intracranial pressure, and papilloedema [40].
These differences may be due to geographic location (Africa vs.
Asia) or patient population (pediatric vs. adult).
Other studies in pediatric populations also suggest that VEGF is
associated with disease severity. A study looking at VEGF levels in
children with sepsis and meningococcemia reported the highest
VEGF levels in patients with septic shock [41] and elevated VEGF
was a useful prognostic indicator in Kawasaki disease, an acute
febrile vasculitis in children [42]. In our study, despite being
elevated in CM-R, VEGF was not a particularly informative
marker, as it was variable between admission and follow up in
Table 3. Biomarker levels in Malawian children with
uncomplicated malaria (UM), retinopathy confirmed cerebral
malaria (CM-R) or non-malarial fever with altered
consciousness (CNS).
UM (n=32) CM-R (n=38) CNS (n=24)
Ang-1, ng/mL 14 (4.2–132)** 3.1 (0.94–9.2) 10 (3.1–69)**
Ang-2, ng/mL 5.2 (2.0–41) 7.6 (3.1–34) 5.08 (1.67–14.29)*
Ang-2:Ang-1 0.39 (0.04–2.6)** 2.3 (0.75–6.6) 0.34 (0.03–2.5)**
sTie-2, ng/mL 48 (32–84)** 66(42–95) 67 (43–124)
VWFpp, nmol/L 32 (10–53)** 70 (13–1127) 23 (8.1–106)**
VWF, nmol/L 144 (23–301)** 357 (157–654) 169 (73–524)**
sICAM-1, ng/mL 660 (447–1761)** 1154 (718–2073) 1016 (675–4358)
VEGF, ng/mL 0.17 (0.02–9.1)* 0.55 (0.02–6.4) 0.46 (0.02–2.9)
IP-10, ng/mL 0.60 (0.05–8.3) 1.0 (0.13–8.1) 0.69 (0.02–2.6)
Median (range);
*p,0.05;
**p,0.01 for difference compared to CM-R (corrected for multiple testing at 18
pair-wise comparisons using Holm’s test).
doi:10.1371/journal.pone.0015291.t003
Table 4. Receiver operating characteristic curves of endothelial biomarkers in children with uncomplicated malaria (UM) or
cerebral malaria with retinopathy (CM-R).
AUROC UM vs.
CM-R (95% CI) p-value Cutoff
Sensitivity
(95%CI)
Specificity
(95%CI)
Positive
likelihood
ratio (95%CI)
Negative
likelihood
ratio (95%CI)
Ang-1 0.96 (0.93–1.0) ,0.0001* 5.3 94 (80–98) 87 (73–94) 7.1 (3.1–16) 0.072 (0.019–0.28)
Ang-2 0.65 (0.51–0.79) 0.0359 6.1 63 (45–77) 71 (55–83) 2.2 (1.2–3.8) 0.53 (0.32–0.86)
Ang-2: Ang-1 0.96 (0.93–1.0) ,0.0001* 0.95 94 (80–98) 95 (83–99) 18 (4.6–69) 0.066 (0.017–0.25)
sTie-2 0.82 (0.72–0.92) ,0.0001* 56 78 (61–89) 74 (58–85) 3.0 (1.7–5.2) 0.30 (0.15–0.59)
VWF propeptide 0.93 (0.87–0.99) ,0.0001* 44 91 (76–97) 84 (70–93) 5.7 (2.7–12) 0.11 (0.038–0.33)
VWF 0.93 (0.88–0.99) ,0.0001* 220 81 (65–91) 84 (70–93) 5.1 (2.4–11) 0.22 (0.11–0.46)
sICAM-1 0.94 (0.87–1.0) ,0.0001* 870 91 (76–97) 92 (79–97) 11 (3.9–34) 0.10 (0.035–0.30)
VEGF 0.71 (0.58–0.84) 0.0025* 0.25 72 (55–84) 74 (58–85) 2.7 (1.5–4.9) 0.38 (0.21–0.69)
IP-10 0.64 (0.50–0.77) 0.0504 0.72 69 (51–82) 66 (49–79) 2.0 (1.2–3.3) 0.48 (0.27–0.83)
Median (range), Mann-Whitney U test;
*p,0.05 after Holms correction for 9 pair-wise comparisons;
CM-R: Cerebral malaria, retinopathy positive
UM: Uncomplicated malaria, AUROC: Area under the receiver operating characteristic curve.
doi:10.1371/journal.pone.0015291.t004
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controls. However, VEGF may be playing an under-appreciated
role in endothelial regulation based on the presence or absence of
Ang-1 or Ang-2 in the local milieu. Consequently, it may be
premature to rule out VEGF as a mediator of severe malaria,
given its diverse functions. It is worth noting that VEGF is
contained primarily within platelets, and plasma levels can be
affected by differences in sample processing (anti-coagulant used,
centrifugation time and speed, etc.). Together, our VEGF data
supports the idea that VEGF may be associated with disease
severity and neurologic complications in CM; however, due to its
local action, future studies are warranted to further elucidate the
role of VEGF in disease severity.
ICAM-1 is upregulated in the cerebral endothelium during
malaria infection and is associated with parasite sequestration within
the cerebral vasculature, a pathological hallmark of CM [17].
sICAM-1 is released by activated endothelium during malaria and
has been reported as a biomarker of disease severity [16,43].
Similarly, in our study, sICAM-1 was able to discriminate between
UM and CM, but it was also elevated in the CNS control group. In
this population, IP-10 was non-significantly elevated in retinopathy-
confirmed CM and displayed poor performance as a biomarker.
Previous reports haveidentified IP-10 as agoodprognostic biomarker
for malaria mortality [19]; however, this could not be assessed in the
current study where fatal cases were excluded. Recent reports have
describedincreasedcirculatingconcentrationsofVWFandactivation
of the coagulation system in severe malaria, with possible implications
for pathogenesis [8,9,37]. It has been postulated that an increase in
ultra large VWF strings and a decrease in its cleavage protein
ADAMTS13 may result in platelet accumulation and contribute to
sequestration of parasitized erythrocytes [23]. In the current study,
both VWF and VWFpp were elevated in CM-R compared to UM or
CNS controls, suggesting that these proteins are also good candidate
biomarkers for CM.
The endothelial proteins measured in this study returned to a
normal range in association with clinical recovery, suggesting that
the alterations in biomarker levels at presentation were mediated
by the infection status of the child rather than a natural host-
mediated susceptibility as a result of genetic or epigenetic changes
in the biomarkers examined. In previous studies, VWFpp was
shown to return to baseline three days after the initiation of anti-
malarial therapy [8], and Ang-2 and the RH-PAT index, a
measure of peripheral endothelial dysfunction, returned to normal
four days post treatment [10].
Insummary, our study is the first to examine apanelof endothelial-
based biomarkers in a well characterized patient population. Recent
investigations have moved towards the inclusion of non-malaria
febrile illness (NMFI) as a control group to investigate the specificity of
markers for malaria infection. In this study, we included a NMFI
group with decreased consciousness, which approximates the
clinically ideal control group, i.e. children with incidental parasitemia
and coma (bacterial meningitis, viral encephalopathy, etc.). CM is a
clinical definition based on the presence of malaria parasitemia and
coma with no other identifiable cause. However, in malaria endemic
areas, there are often resource constraints that make exclusion of
alternative causes of coma problematic.
The results of this study are encouraging, and suggest that a
limited panel of endothelial biomarkers may be useful in
differentiating between retinopathy positive CM and non-malarial
febrile illness with decreased consciousness. However, these results
will need to be confirmed in prospective studies and assessed
Table 5. Receiver operating characteristic curves of endothelial biomarkers in children with fever and altered consciousness (CNS)
or cerebral malaria with retinopathy (CM-R).
AUROC CNS vs.
CM-R p-value Cutoff
Sensitivity
(95%CI)
Specificity
(95%CI)
Positive
likelihood
ratio (95%CI)
Negative
likelihood
ratio (95%CI)
Ang-1 0.93 (0.88–0.99) ,0.0001* 5.3 88 (69–96) 87 (73–94) 6.7 (2.9–15) 0.14 (0.05–0.42)
Ang-2 0.71 (0.55–0.84) 0.006* 6.3 67 (47–82) 71 (55–83) 2.3(1.3–4.1) 0.47 (0.26–0.86)
Ang-2: Ang-1 0.93 (0.87–0.99) ,0.0001* 1.4 71 (51–85) 95 (83–99) 13 (3.4–53) 0.31 (0.16–0.58)
sTie-2 0.62 (0.49–0.78) 0.1087 66 8.3 (2.3–26) 74 (58–85) 1.2 (0.99–1.6) 0.32 (0.076–1.3)
VWF propeptide 0.89(0.80–0.98) ,0.0001* 38 79 (60–91) 84 (70–93) 5.0 (2.3–11) 0.25 (0.11–0.55)
VWF 0.80 (0.66–0.92) ,0.0001* 310 63 (43–79) 84 (70–93) 4.0 (1.8–8.8) 0.45 (0.26–0.76)
sICAM-1 0.59 (0.41–0.74) 0.254 1000 38 (21–57) 92 (79–97) 4.8 (1.4–16) 0.68 (0.49–0.94)
VEGF 0.54 (0.39–0.69) 0.587 0.53 39 (22–59) 74 (58–85) 1.5 (0.71–3.1) 0.83 (0.57–1.2)
IP-10 0.64 (0.50–0.78) 0.0673 0.91 52 (33–71) 66 (50–79) 1.5 (0.85–2.8) 0.73 (0.45–1.2)
Median (range), Mann-Whitney U test;
*p,0.05 after Holms correction for 9 pair-wise comparisons;
CM-R: Cerebral malaria, retinopathy positive.
CNS: children with non-malarial fever with decreased consciousness, AUROC: Area under the receiver operating characteristic curve.
doi:10.1371/journal.pone.0015291.t005
Table 6. Two-way rank correlations between biomarkers.
Ang-2 Tie-2 VWFpp VWF sICAM-1 VEGF IP-10
Ang-1 20.21
** 20.10 20.55
** -0.63
** 20.51
** 0.034 20.18
*
Ang-2 0.33
** 0.55
** 0.42
** 0.36
** 0.12 0.54
**
sTie-2 0.251
** 0.25
** 0.44
** 0.17 0.13
VWFpp 0.80
** 0.58
** 0.055 0.57
**
VWF 0.60
** 0.14 0.37
**
sICAM-1 0.16 0.43
**
VEGF 0.25
**
Spearman’s rho;
*p,0.05;
**p,0.01;
n=123.
doi:10.1371/journal.pone.0015291.t006
Biomarkers for Cerebral Malaria
PLoS ONE | www.plosone.org 8 December 2010 | Volume 5 | Issue 12 | e15291alongside other infectious causes of coma in paediatric populations.
Furthervalidationofbiomarkersneedstobeperformedtodetermine
whether these markers: i) are informative in stratifying subjects in
clinical trials or pathogenesis studies; ii) may have clinical utility in
the diagnosis oftrue CM, assessment of diseaseseverity and response
to therapy (allocation of resources), or to determine prognosis; and
iii) represent novel therapeutic targets for adjunctive therapy.
Supporting Information
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Figure 3. Biomarker levels at admission and follow up. Plasma levels of biomarkers were measured at admission and 28 days post-treatment
in a cohort of retinopathy positive children with cerebral malaria. Wilcoxon signed rank test with Holms correction (9 pair-wise comparisons) was
used to compare levels of (A) Ang-2 (ng/mL); sum of signed ranks (W), (W, p-value: 746, p,0.0009); (B) Ang-1 (ng/mL), (W, p-value: 2741, p,0.0009);
(C) Ang-2:Ang-1, (W, p-value: 741, p,0.0009); (D) VWF propeptide (nM), (W, p-value: 768, p,0.0009); (E) VWF (nM), (W, p-value: 740, p,0.0009); (F)
sTie-2 (ng/mL) (W, p-value: 754, p,0.0009); (G) sICAM-1 (ng/mL), (W, p-value: 732, p,0.0009); (H) VEGF (ng/mL), (W, p-value: 2388, p=0.001); and (I)
IP-10 (ng/mL), (W, p-value: 607, p,0.0009).
doi:10.1371/journal.pone.0015291.g003
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